Background Mycoplasma genitalium is now recognised as an important bacterial sexually
transmitted infection. We summarised data from studies of mutations associated with …

The emergence of antimicrobial resistance (AMR) is a major concern worldwide and already
compromises treatment effectiveness and control of several bacterial sexually transmitted …

Macrolide resistance mechanisms can be target-based with a change in a 23S ribosomal
RNA (rRNA) residue or a mutation in ribosomal protein L4 or L22 affecting the ribosome's …

This is the first British Association for Sexual Health and HIV (BASHH) guideline for the
diagnosis and management of Mycoplasma genitalium in people aged 16 years and older …

The prevalence rates of Mycoplasma genitalium infections and coinfections with other
sexually transmitted organisms and the frequency of a macrolide antibiotic resistance …

Background. Our aim was to determine the efficacy of 1 g azithromycin and alternative
antibiotic regimens in a prospective cohort of Mycoplasma genitalium–infected participants …

Background. Mycoplasma genitalium (MG) is associated with nongonococcal urethritis in
men and cervicitis in women. Current guidelines recommend treatment with 1 gram of …

Mycoplasma genitalium is an etiological agent of sexually transmitted infections, but due to
its fastidious growth requirements, only a few M. genitalium strains are available for …

Mycoplasmata have been linked to pregnancy complications and neonatal risk. While
formerly a limited number of species could be discovered by cultures, molecular biology …

Objectives To evaluate therapy for Mycoplasma genitalium infection with doxycycline or
azithromycin 1 g compared to five days of azithromycin (total dose 1.5 g). Methods A …